These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18770360)

  • 1. Quantitative pathogenicity of Marek's disease virus and vaccine virus strains in chickens: macroscopical aspects.
    Maas HJ; Orthel FW; Rispens BH; Tittes EV; De Kort MF; Vreede-Groenewegen AE; Jansen J; Hartog L
    Avian Pathol; 1978 Jan; 7(1):61-78. PubMed ID: 18770360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
    Eidson CS; Villegas P; Page RK; Kleven SH
    Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV.
    Geerligs HJ; Weststrate MW; Pertile TL; Rodenberg J; Kumar M; Chu S
    Acta Virol; 1999; 43(2-3):198-200. PubMed ID: 10696445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity studies with plaque-purified preparations of Marek's disease virus strain CVI-988.
    Pol JM; Kok GL; Oei HL; de Boer GF
    Avian Dis; 1986; 30(2):271-5. PubMed ID: 3015112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
    Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
    Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection between JMV Marek's disease-derived tumour transplant, Marek's disease and turkey herpesviruses.
    Bulow VV
    Avian Pathol; 1977; 6(4):353-66. PubMed ID: 18770345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of very virulent Marek's disease viruses isolated in Japan.
    Imai K; Yuasa N; Iwakiri H; Nakamura K; Hihara H; Ishita T; Inamoto A; Okamoto I; Ohta K; Maeda M
    Avian Pathol; 1992; 21(1):119-26. PubMed ID: 18670921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C; Nervi P; Risso M
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity for chicks of line cells from lymphoma of Marek's disease.
    Doi K; Kojima A; Akiyama Y; Kato S
    Natl Inst Anim Health Q (Tokyo); 1976; 16(1):16-24. PubMed ID: 177892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further characterisation of the CVI 988 strain of Marek's disease virus.
    Bülow VV
    Avian Pathol; 1977; 6(4):395-403. PubMed ID: 18770348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive effects of Marek's disease virus (MDV) and herpesvirus of turkeys (HVT) in broiler chickens and the protective effect of HVT vaccination against MDV challenge.
    Islam AF; Wong CW; Walkden-Brown SW; Colditz IG; Arzey KE; Groves PJ
    Avian Pathol; 2002 Oct; 31(5):449-61. PubMed ID: 12427339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Marek's disease virus load in peripheral blood lymphocytes at various stages of infection and clinical Marek's disease in broiler chickens.
    Islam AF; Walkden-Brown SW; Islam A; Underwood GJ; Groves PJ
    Avian Pathol; 2006 Feb; 35(1):42-8. PubMed ID: 16448942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
    Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
    Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cell line system susceptible to infection with vaccine strains of MDV.
    Abujoub AA; Williams DL; Reilly JD
    Acta Virol; 1999; 43(2-3):186-91. PubMed ID: 10696443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus.
    Witter RL
    Avian Pathol; 1982; 11(1):49-62. PubMed ID: 18770172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.